Literature DB >> 7438124

Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results.

K Mattson, L R Holsti, M Salmo, M Saastamoinen, S Ahlstedt, P Holsti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7438124     DOI： 10.1016/s0305-7372(80)80010-7

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  4 in total

Review 1.  Chemotherapy of advanced non-small cell lung cancer. A review.

Authors:  B J Takasugi; T P Miller
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

2.  Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.

Authors:  J Z Fuks; M J Egorin; J Aisner; D A Van Echo; S Ostrow; N R Bachur; P H Wiernik
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer.

Authors:  S G Allan; A Gregor; M A Cornbleet; R C Leonard; J F Smyth; I W Grant; G K Crompton
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.

Authors:  B D Evans; I E Smith; A J Shorthouse; J L Millar
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.